Peter Harrison, the CEO and Director of Bioventix PLC, recently made a notable investment by purchasing £39,000 worth of shares at £18.49 each. This transaction represents the largest insider purchase in the past year, suggesting a degree of optimism about the company's prospects, especially as the current share price stands at £18.50. While the increase in Harrison's shareholding is minimal, the fact that no insiders have sold shares during this period may indicate confidence in the company's future. Currently, insiders hold 6.1% of Bioventix shares, valued at around £5.9 million. Despite these positive signals, potential investors should remain aware of the risks associated with Bioventix, as there is at least one identified warning sign that could impact investment decisions.